Increasing evidence suggests that systemic low-grade inflammation may be a driving force of cardiometabolic complications, such as vascular dysfunction, atherosclerosis and ischemic heart disease. Thus, we will investigate the role of inflammation in cardiovascular disease.
| Facility | City | Region | Status |
|---|---|---|---|
| University of Gothenburg | Gothenburg | Vastragotaland | Recruiting |
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT03732612 on ClinicalTrials.gov ↗ ← All trials in Sweden